Document and Entity Information
Document Type
Document Annual Report
Document Period End Date
Current Fiscal Year End Date
Document Fiscal Year Focus
Document Transition Report
Entity File Number
Entity Registrant Name
Entity Incorporation, State or Country Code
Entity Tax Identification Number
Entity Address, Address Line One
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Postal Zip Code
City Area Code
Local Phone Number
Title of 12(b) Security
Trading Symbol
Security Exchange Name
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
ICFR Auditor Attestation Flag
Document Financial Statement Error Correction [Flag]
Entity Shell Company
Auditor Firm ID
Auditor Name
Auditor Location
Entity Public Float
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Entity Central Index Key
Document Fiscal Period Focus
Amendment Flag
Balance Sheets
Statement [Table]
Statement [Line Items]
Statement
Assets [Abstract]
Assets
Assets, Current [Abstract]
Current Assets
Cash and Cash Equivalents, at Carrying Value
Cash
Cash and cash equivalents
Prepaid Expense and Other Assets, Current
Total prepaid expenses and other current assets
Prepaid expenses and other current assets
Assets, Current
Total Current Assets
Crypto Asset, Fair Value, Noncurrent
HYPE digital tokens
Digital assets
Amount, after unamortized nonrefundable upfront fee and allowance for credit loss, of crypto assets receivable, classified as non current.
Crypto Assets Receivable, After Unamortized Nonrefundable Upfront Fee And Allowance For Credit Loss, Non Current
Digital assets receivable, net
Indefinite-Lived Intangible Assets (Excluding Goodwill)
Digital intangible assets
Digital intangible assets, Carrying value
Operating Lease, Right-of-Use Asset
Operating lease right-of-use asset
Other Assets, Noncurrent
Other assets
Assets
Total Assets
Liabilities and Equity [Abstract]
Liabilities and Stockholders' Equity (Deficit)
Liabilities, Current [Abstract]
Current Liabilities:
Accounts Payable, Current
Accounts payable
Obligations incurred on contractual termination, that are expected to be paid during the following twelve months or within one business cycle, if longer.
Accrued Former License Obligation, Current
Accrued former licensor obligations
Carrying value as of the balance sheet date of obligations incurred and payable, of accrued expenses and other current liabilities.
Accrued Expenses and Other Liabilities, Current
Accrued expenses and other current liabilities
Operating Lease, Liability, Current
Less: current portion
Operating lease liabilities - current portion
Short-term Bank Loans and Notes Payable
Short term notes payable
Notes payable - current portion, net of debt discount of $0 and $527,870 as of December 31, 2025 and December 31, 2024, respectively
Convertible Notes Payable, Current
Convertible notes payable - net of debt discount of $0 and $263,930 as of December 31, 2025 and December 31, 2024, respectively
Liabilities, Current
Total Current Liabilities
Other Notes Payable, Noncurrent
Notes payable - non-current portion, net of debt discount of $543,230 and $0 as of December 31, 2025 and December 31, 2024, respectively
Operating Lease, Liability, Noncurrent
Lease liabilities, non-current portion
Operating lease liabilities, non-current portion
Liabilities
Total Liabilities
Commitments and Contingencies.
Commitments and contingencies (Note 11)
Stockholders' Equity Attributable to Parent [Abstract]
Stockholders' Equity (Deficit):
Preferred Stock, Value, Issued
Preferred stock, $0.0001 par value, 60,000,000 shares authorized; Series A Non-Voting Convertible Preferred Stock, 5,435,898 shares designated, and 5,435,897 and 0 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively, with a liquidation preference of $50,795,000 as of December 31, 2025
Common Stock, Value, Outstanding
Common stock, $0.0001 par value, 600,000,000 shares authorized; 8,762,329 shares issued and 8,680,005 shares outstanding as of December 31, 2025 and 1,506,369 shares issued and outstanding as of December 31, 2024
Additional Paid in Capital
Additional paid-in capital
Treasury Stock, Common, Value
Treasury stock, at cost, 82,324 shares as of December 31, 2025
Retained Earnings (Accumulated Deficit)
Accumulated deficit
Stockholders' Equity Attributable to Parent
Balance at the end
Balance at the beginning
Total Stockholders' Equity (Deficit)
Liabilities and Equity
Total Liabilities and Stockholders' Equity (Deficit)
Class of Stock [Axis]
Class of Stock [Domain]
Series A Preferred Stock [Member]
Series A Preferred Stock
Series A Convertible Preferred
Amount of discount on notes payable to be amortized within one year or within the normal operating cycle, if longer.
Notes Payable, Unamortized Discount, Current
Notes payable - current portion, net of debt discount
Amount of discount on convertible notes payable to be amortized within one year or within the normal operating cycle, if longer.
Convertible Notes Payable, Unamortized Discount, Current
Convertible notes payable - net of debt discount
Amount of discount on notes payable to be amortized after one year or the normal operating cycle, if longer.
Notes Payable, Unamortized Discount, Noncurrent
Notes payable - non-current portion, net of debt discount
Preferred Stock, Par or Stated Value Per Share
Preferred stock, par value
Preferred Stock, Shares Authorized
Preferred stock, shares authorized
Preferred Stock, Shares Issued
Preferred stock, shares issued
Preferred Stock, Shares Outstanding
Preferred stock, shares outstanding
Preferred Stock, Liquidation Preference, Value
Liquidation preference
Preferred stock liquidation preference
Common Stock, Par or Stated Value Per Share
Common stock, par value
Common Stock, Shares Authorized
Common stock, shares authorized
Common Stock, Shares, Issued
Common stock, shares issued
Common Stock, Shares, Outstanding
Common stock, shares outstanding
Treasury Stock, Common, Shares
Treasury stock balance at the end (in shares)
Treasury stock balance at the beginning (in shares)
Treasury stock, at cost, shares
Statements of Operations
Revenue from Contract with Customer, Excluding Assessed Tax
Revenue
Cost of Revenue
Cost of revenue
Gross Profit
Gross Profit (Loss)
Gross Income (Loss)
Operating Income (Loss) [Abstract]
Operating (Income) Expenses:
Research and Development Expense
Research and development
Selling, General and Administrative Expense
Selling, general and administrative
Crypto Asset, Realized Gain (Loss), Operating
Realized gains - digital assets
Realized gain - digital assets
Crypto Asset, Unrealized Gain (Loss), Operating
Unrealized loss - digital assets
Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)
Impairment loss - digital assets
Impairment loss - digital assets
The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.
Other Asset Impairment Loss
Impairment loss - other assets
Asset impairments
Amount of gain (loss) on covered call option recognized during the period.
Gain (Loss) On Covered Call Option
Gain on covered call option
Amount of expense for credit loss on crypto assets receivable.
Crypto Assets Receivable, Provision For Credit Loss
Provision for credit loss
Provision for credit losses
Allowance for credit losses
Amount of expense on reacquisition of license rights.
Reacquisition Of License Rights
Reacquisition of license rights
Operating Expenses
Net Operating Expenses
Operating Income (Loss)
Loss From Operations
Nonoperating Income (Expense) [Abstract]
Other Income (Expense):
Other Nonoperating Income (Expense)
Other income (expense), net
Difference between the fair value of payments made and the carrying amount of liability which is extinguished prior to maturity.
Gain (Loss) on Extinguishment of Liability
Gain on extinguishment of liabilities
Gain on extinguishment of liabilities
Gain (Loss) on Extinguishment of Debt
Gain on debt extinguishment
Amount of change in fair value of equity consideration payable.
Change in Fair Value of Equity Consideration Payable
Change in fair value of equity consideration payable
Change in fair value of equity consideration payable
Interest Expense Nonoperating
Interest expense
Interest expense
Investment Income, Interest
Interest income
Nonoperating Income (Expense)
Total Other Income (Expense), Net
Other (income) expense, net
Net loss
Net Loss
Net loss
Preferred Stock Dividends, Income Statement Impact
Dividend to preferred stockholders
Net Income (Loss) Available to Common Stockholders, Basic
Net Loss Attributable to Common Stockholders
Net loss attributable to common stockholders
Net Loss Per Share of Common Stock
Net Loss per Share
Earnings Per Share, Basic
Net Loss per Share - Basic (in dollars per share)
Basic net loss per common share (in dollars per share)
Earnings Per Share, Diluted
Net Loss per Share - Diluted (in dollars per share)
Diluted net loss per common share (in dollars per share)
Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]
Shares Outstanding
Weighted Average Number of Shares Outstanding, Basic
Denominator for basic net loss per share (in shares)
Shares Outstanding - Basic (in shares)
Weighted Average Number of Shares Outstanding, Diluted
Denominator for diluted net loss per share (in shares)
Shares Outstanding - Diluted (in shares)
Statements of Changes in Stockholders' (Deficit) Equity
Equity Components [Axis]
Equity Component [Domain]
Preferred Stock [Member]
Preferred Stock
Common Stock [Member]
Common Stock
Additional Paid-In Capital [Member]
Additional Paid-In Capital
Treasury Stock, Common [Member]
Treasury Stock
Accumulated Deficit [Member]
Accumulated Deficit
Shares, Outstanding
Balance at the end (in shares)
Balance at the beginning (in shares)
Equity impact of the value of new stock issued during the period. Includes shares issued in a private placement.
Stock Issued During Period, Value, New Issues, Private Placement
Issuance of preferred stock and warrants in private placement
Number of new stock issued in a private placement during the period.
Stock Issued During Period, Shares, New Issues, Private Placement
Issuance of preferred stock and warrants in private placement (in shares)
The amount of common stock issued in at the market offering.
Stock Issued at Market Offering During Period Value New Issues
Issuance of common stock in At the Market offering
This represents shares issued at market offering.
Stock Issued at Market Offering During Period Shares New Issues
Issuance of common stock in At the Market offering (in shares)
Represent stock issued during period value licensing agreements.
Stock Issued During Period, Value, Licensing Agreements
Issuance of common stock as consideration for licensing agreement
Pursuant to the license and certain milestone achievements stock
Represent stock issued period shares licensing agreements.
Stock Issued During Period, Shares, Licensing Agreements
Issuance of common stock as consideration for licensing agreement (in shares)
Pursuant to the license and certain milestone achievements issued
Represent stock issued during the period, value for reacquisition of licensing agreements.
Stock Issued During Period Value, Reacquisition Of Licensing Agreement
Issuance of common stock as consideration for reacquisition of licensing agreement
Pursuant to the Letter Agreement stock
Represent stock issued period, shares for reacquisition of licensing agreement.
Stock Issued During Period Shares, Reacquisition Of Licensing Agreement
Issuance of common stock as consideration for reacquisition of licensing agreement (in shares)
Pursuant to the Letter Agreement shares
Stock Issued During Period, Value, New Issues
Issuance of common stock and warrants in offerings
Stock Issued During Period, Shares, New Issues
Number of common shares issued
Issuance of common stock and warrants in offerings (in shares)
Value of stock issued as a result of the exercise of warrants.
Stock Issued During Period Value Warrants Exercised
Issuance of common stock from exercise of warrants
Number of shares issued as a result of the exercise of warrants.
Stock Issued During Period Shares Warrants Exercised
Issuance of common stock from exercise of warrants (in shares)
Equity impact of the value of new stock issued during the period upon induced exercise of warrants.
Stock Issued During Period, Value, Induced Exercise of Warrants
Induced exercise of stock warrants
Number of new stock issued upon induced exercise of warrants.
Stock Issued During Period, Shares, Induced Exercise of Warrants
Induced exercise of stock warrants (in shares)
Stock Issued During Period, Value, Conversion of Convertible Securities
Issuance of common stock from the partial conversion of note payable
Stock Issued During Period, Shares, Conversion of Convertible Securities
Issuance of common stock from the partial conversion of note payable (in shares)
Amount of restricted stock issued during the period.
Restricted Stock Issued During Period Value New Issues
Issuance of common stock from the delivery of vested restricted stock units
This represents restricted stock units issued during the period.
Restricted Stock Issued During Period Shares New Issues
Issuance of common stock from the delivery of vested restricted stock units (in shares)
Adjustments to Additional Paid in Capital, Warrant Issued
Warrant modification and additional warrants - incremental value
Treasury Stock, Value, Acquired, Cost Method
Shares withheld for employee payroll taxes
Treasury Stock, Shares, Acquired
Shares withheld for employee payroll taxes (in shares)
Shares were withheld for RSUs
Adjustments to Additional Paid in Capital, Stock Split
Reverse stock split settlement of fractional shares
Stock Issued During Period, Shares, Reverse Stock Splits
Reverse stock split settlement of fractional shares (in shares)
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
Warrants issued in consideration for debt modification
Adjustments to additional paid in capital upon stock issuance costs
Value of shares issued during the period as a result of loan modification.
Stock Issued During Period, Value, Loan Modification
Issuance of common stock as consideration for modification of loan agreement
Number of shares issued during the period as a result of loan modification.
Stock Issued During Period, Shares, Loan Modification
Issuance of common stock as consideration for modification of loan agreement (in shares)
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition [Abstract]
Stock-based compensation:
APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition
Amortization of stock option awards
APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
Amortization of restricted stock units
Stock Issued During Period, Value, Issued for Services
Value of received securities
Issuance of common stock to vendors in consideration for service provided
Stock Issued During Period, Shares, Issued for Services
Compensation received for services
Issuance of common stock to vendors in consideration for service provided (in shares)
Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings
Preferred stock dividend ($0.59 per preferred share outstanding)
Sale of Stock [Axis]
Sale of Stock [Domain]
At Market Offering [Member]
At Market Offering
At Market Offering
Private Placement [Member]
Private Placement
Preferred Stock, Dividend Rate, Per-Dollar-Amount
Preferred stock dividend rate
The amount of issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.
Proceeds Of Stock Issued During Period Gross
Proceeds of stock issued during period gross
Payments of Stock Issuance Costs
Issuance costs
The cash inflow from the additional capital contribution to the entity.
Proceeds from Issuance of Common Stock and Warrants
Gross proceeds from common stock warrants
Proceeds from Warrant Exercises
Proceeds from exercise of stock warrants
Proceeds from exercise of warrants
The cash inflow associated with the amount received on induced exercise of warrants.
Proceeds From Induced Exercise of Warrants
Proceeds from induced exercise of stock warrants
The cash outflow for cost incurred directly with the stock issuance costs on exercise of warrants.
Payments For Stock Issuance Costs, Warrants Exercises
Issuance costs warrants exercises
Statements of Cash Flows
Net Cash Provided by (Used in) Operating Activities [Abstract]
Cash Flows From Operating Activities
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Share-Based Payment Arrangement, Noncash Expense
Stock-based compensation
Depreciation, Depletion and Amortization
Depreciation of property and equipment
Amount of Amortization of debt discount.
Amortization of Debt Discount
Amortization of debt discount
Inventory Write-down
Write-down of inventories to net realizable value
Amount of non cash expense on reacquisition of license rights.
Non cash Expenses On Reacquisition Of License Rights
Reacquisition of license rights
Amount of expense (income) related to the increase (decrease) in reserve for lease expenses.
Non Cash Lease Expense
Non-cash lease expense
Amount of realized gain (loss) from remeasurement of crypto asset included in net income that results in no cash inflow (outflow).
Noncash Realized Gain (Loss) On Crypto Asset
Non-cash realized gain - digital assets
The amount of income earned from staking tokens, a virtual digital asset (VDA), on a block chain network or platform that supports staking.
Crypto Asset, Staking Income
Staking income
Amount of commission paid to co-validators included in net income that results in no cash inflow (outflow).
Non Cash Commission Paid To Co Validators
Non-cash commission paid to co-validators
Amount of unamortized nonrefundable upfront fee related to digital assets receivable during the reporting period.
Crypto Assets Receivable, Unamortized Nonrefundable Upfront Fee
Unamortized nonrefundable upfront fee
Unamortized non-refundable upfront fee on digital asset receivable
Paid-in-Kind Interest
Paid-in-kind interest expense
Increase (Decrease) in Operating Capital [Abstract]
Changes in operating assets and liabilities:
Increase (Decrease) in Prepaid Expense and Other Assets
Prepaid expenses and other current assets
The increase (decrease) during the reporting period in the amount of license fee and expense reimbursements receivables.
Increase (Decrease) in License Fee and Expense Reimbursements Receivables
License fee and expense reimbursement receivables
The increase (decrease) during the reporting period in the value of deferred clinical supply costs.
Increase (Decrease) in Deferred Clinical Supply Costs
Deferred clinical supply costs
Increase (Decrease) in Security Deposits
Security and equipment deposits
Increase (Decrease) in Accounts Payable
Accounts payable
Increase (Decrease) in Accrued Liabilities
Accrued compensation
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Accrued expenses and other current liabilities
Increase (Decrease) in Operating Lease Liability
Lease liabilities
Net Cash Provided by (Used in) Operating Activities
Cash used in operating activities
Net Cash and Cash Equivalents Used In Operating Activities
Net Cash Provided by (Used in) Investing Activities [Abstract]
Cash Flows From Investing Activities
Payments to Acquire Property, Plant, and Equipment
Purchase of property and equipment
Amount of cash outflow associated with the acquisition of productive intangible assets including, but not limited to crypto asset and other intangible assets.
Payments To Acquire Productive Intangible Assets
Purchase of productive digital assets
Net Cash Provided by (Used in) Investing Activities
Net Cash and Cash Equivalents Used In Investing Activities
Net Cash Provided by (Used in) Financing Activities [Abstract]
Cash Flows From Financing Activities
The cash inflow from proceeds from sale of common stock and warrants in registered direct offering.
Proceeds from Sale of Common Stock and Warrants in Registered Direct Offering
Proceeds from sale of common stock and warrants in direct offering
The cash inflow associated with issuance of preferred stock and warrants under private placement.
Proceeds From Issuance Of Preferred Stock and Warrants, Private Placement
Proceeds from sale of preferred stock and warrants in private placement
The cash outflow for cost incurred directly with the issuance of an equity security in a private placement.
Payments Of Stock Issuance Costs, Private Placement
Payment of private placement issuance costs
The amount of proceeds from issuance of common stock at market offering.
Proceeds from Issuance of Common Stock at Market Offering
Proceeds from sale of common stock in At the Market offering
The cash outflow for cost incurred directly in at the market offering with the issuance of an equity security.
Payments of Stock Issuance Costs, At the Market Offering
Payment of issuance costs for At the Market offering
The cash associated with costs incurred on induced exercise of warrants.
Payments of Costs on Induced Exercise of Warrants
Payment of cash issuance costs for induced exercise of stock warrants
The amount of reverse stock split settlement of fractional shares.
Reverse Stock Split Settlement of Fractional Shares
Reverse stock split settlement of fractional shares
Payments of Debt Restructuring Costs
Payment of issuance costs for debt modification
Payments of debt restructuring costs
Repayments of Notes Payable
Repayments of notes payable
Payments of Ordinary Dividends, Preferred Stock and Preference Stock
Payment of preferred dividend
Payment for Debt Extinguishment or Debt Prepayment Cost
Payment of costs in connection with debt extinguishment
Net Cash Provided by (Used in) Financing Activities
Net Cash and Cash Equivalents Provided By Financing Activities
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Net Increase (Decrease) in Cash and Cash Equivalents
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Cash and Cash Equivalents - End of Year
Cash and Cash Equivalents - Beginning of Year
Supplemental Cash Flow Information [Abstract]
Supplemental Disclosure of Cash Flow Information:
Interest Paid, Capitalized, Investing Activities
Interest
Income Taxes Paid, Net
Taxes
Total
Noncash Investing and Financing Items [Abstract]
Supplemental Disclosure of Non-Cash Investing and Financing Activities
The amount of crypto asset deposited into liquid staking activities.
Deposits of Crypto Asset Into Liquid Staking Activities
Deposits of HYPE into liquid staking activities
The amount of redemption of liquid staking tokens for crypto assets.
Redemption Of Liquid Staking Tokens For Crypto Assets
Redemption of liquid staking tokens for HYPE
The amount of transfer of crypto assets to digital asset receivable.
Transfer Of Crypto Assets To Digital Asset Receivable
Transfer of HYPE to digital asset receivable
Amount of accrued dividend payable classified as non cash activity.
Accrued Dividend Payable
Accrued dividend payable
The amount of purchase of insurance premium financed by short term notes payable.
Purchase of Insurance Premium Financed by Short Term Note Payable
Purchase of insurance policy financed by note payable
Amount of accrual related to intangible asset recorded in milestone obligation as part of non-cash investing and financing activity.
Accrual for Intangible Assets Milestone Obligation
Accrual for intangible asset milestone obligation
Amount of reclassification of deferred clinical supply costs to inventories.
Reclassification Of Deferred Clinical Supply Costs To Inventories
Reclassification of deferred clinical supply costs to inventories
Extinguishment of Debt, Amount
Modification date carrying value of extinguished Avenue Loan
The fair value of debt modified at the modification date in noncash investing or financing activities.
Modification of Debt, Fair Value at Modification Date
Modification date fair value of modified Avenue Loan
The value of warrants issued for debt modification in noncash financing activities.
Warrants Issued for Debt Modification
Warrants issued for debt modification
Warrant modification and additional warrants incremental value.
Warrant Modification And Additional Warrants Incremental Value
Warrant modification and additional warrants - incremental value
The value of stock reduced for equipment received in conjunction with the license agreement in a non-cash transaction.
Stock Value Adjustment For Equipment Received Under License Agreement
Common stock issued in consideration for equipment received in conjunction with licensing agreement
Debt Conversion, Converted Instrument, Amount
Conversion of principal amount outstanding
Conversion of Avenue Loan to common stock
Stock Issued
Common stock issued in consideration for licensing agreement
The fair value of stock issued for reacquisition of licensing agreement in noncash financing activities.
Stock issued, Value, Reacquisition Of Licensing Agreement
Common stock issued in consideration for reacquisition of licensing agreement
The value of stock issued as a consideration for loan modification in a noncash financing activities.
Stock Issued For Loan Modification
Common stock issued as consideration for modification of loan agreement
Interest Costs Capitalized
Interest expense added to the principal balance outstanding
Interest expense added to note principal
The amount of issuance of common stock related to vested restricted stock units.
Issuance of Common Stock Related to Vested Restricted Stock Units
Issuance of common stock related to vested restricted stock units
Amount of treasury stock held for employee payroll taxes upon the delivery of restricted stock units.
Treasury Stock Held For Employee Payroll Taxes
Treasury stock held for employee payroll taxes upon the delivery of restricted stock units
Business Organization, Nature of Operations and Basis of Presentation
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Business Organization, Nature of Operations and Basis of Presentation
No definition available.
Management's Liquidity Plans
The entire disclosure for management's liquidity plan.
Liquidity Plan, Disclosure [Text Block]
Management's Liquidity Plans
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Summary of Significant Accounting Policies
Earnings Per Share [Text Block]
Net Loss Per Share of Common Stock
Prepaid Expenses and Other Current Assets
The entire disclosure of prepaid expenses and other current assets.
Prepaid Expenses and Other Current Assets Disclosure [Text Block]
Prepaid Expenses and Other Current Assets
Other Intangible Assets
Intangible Assets Disclosure [Text Block]
Other Intangible Assets
The entire disclosure for digital assets.
Digital Assets Disclosure [Text Block]
Digital Assets
Accrued Expenses and Other Current Liabilities
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]
Accrued Expenses and Other Current Liabilities
Notes Payable
The entire disclosure of notes payable.
Notes Payable Disclosure [Text Block]
Notes Payable
Income Taxes
Income Tax Disclosure [Text Block]
Income Taxes
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Commitments and Contingencies
Related Party Transactions
Related Party Transactions Disclosure [Text Block]
Related Party Transactions
Stockholders' Equity (Deficit)
Stockholders' Equity Note Disclosure [Text Block]
Stockholders' Equity (Deficit)
Employee Benefit Plans
Compensation and Employee Benefit Plans [Text Block]
Employee Benefit Plans
Segment Reporting
Segment Reporting Disclosure [Text Block]
Segment Reporting
Subsequent Events
Subsequent Events [Text Block]
Subsequent Events
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and Cash Equivalents
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]
Impairment of Long-lived Assets
Disclosure of accounting policies for digital assets.
Digital Assets, Policy [Policy Text Block]
Digital Assets
Fair Value Measurement, Policy [Policy Text Block]
Fair Value Measurement
Income Tax, Policy [Policy Text Block]
Income Tax
Revenue from Contract with Customer [Policy Text Block]
Ophthalmic Technology Revenue
Disclosure of accounting policy for arctic vision license agreement.
Arctic Vision License Agreement [Policy Text Block]
Arctic Vision License Agreement
Disclosure of accounting policy for bausch license agreement.
Bausch License Agreement [Policy Text Block]
Bausch License Agreements
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]
Intangible Assets
Lessee, Leases [Policy Text Block]
Operating Leases
Research and Development Expense, Policy [Policy Text Block]
Research and Development
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Stock-Based Compensation
Subsequent Events, Policy [Policy Text Block]
Subsequent Events
Disclosure of accounting policy pertaining to new accounting pronouncements issued that may impact the entity's financial reporting.
New Accounting Pronouncements Issued, Policy [Policy Text Block]
Recently Issued Accounting Standards
New Accounting Pronouncements, Policy [Policy Text Block]
Recently Adopted Accounting Standards
Reclassification, Comparability Adjustment [Policy Text Block]
Reclassifications
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Schedule of digital assets subject to fair value measurements on a recurring basis and the level of inputs used for such measurements
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Schedule of computation of basic and diluted net loss per common share
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of securities are excluded from the calculation of weighted average diluted shares of common stock
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]
Schedule of prepaid expenses and other current assets
Crypto Asset, Activity [Table Text Block]
Schedule of digital asset reconciliation
Crypto Asset, Holding [Table Text Block]
Schedule of digital assets
Schedule of Indefinite-Lived Intangible Assets [Table Text Block]
Schedule of digital intangible assets
Schedule of Accrued Liabilities [Table Text Block]
Schedule of accrued expenses and other current liabilities
Tabular disclosure of notes payable.
Schedule of Notes Payable [Table Text Block]
Schedule of notes payable and convertible notes payable
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
Schedule of provision for income taxes
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
Schedule of effective income tax rate reconciliation
Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]
Schedule of amount of cash taxes paid
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
Schedule of deferred tax assets
Lease, Cost [Table Text Block]
Schedule of company's right-of-use assets and liabilities
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Schedule of future minimum payments under the company's operating lease agreements
Schedule of Stockholders Equity [Table Text Block]
Schedule of 2024 offerings
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
Schedule of fair value assumptions used for warrant liability
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
Schedule of the warrant activity and related information
The tabular disclosure of warrants outstanding.
Schedule Of Warrants Outstanding [Table Text Block]
Schedule of warrants outstanding
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Schedule of stock-based compensation expense
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]
Summary of restricted stock units ("RSUs") activity
Tabular disclosure of the significant assumptions used during the year to estimate the fair value of options other than equity instruments, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.
Schedule of Share-Based Payment Award, Options Other Than Equity Instruments, Valuation Assumptions [Table Text Block]
Schedule of Barrier option pricing model to restricted stock units granted
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Summary of the option activity
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]
Schedule of information related to stock options
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Schedule of Black-Scholes option pricing model to stock options granted
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Schedule of activity of Company's segments
Reconciliation of Assets from Segment to Consolidated [Table Text Block]
Schedule of segment assets
Stockholders' Equity Note, Stock Split, Conversion Ratio
Reverse stock split ratio
Disclosure of information about liquidity plan.
Liquidity Plan [Table]
Crypto Asset [Axis]
Crypto Asset [Domain]
Represents information pertaining to Hype digital assets.
Hype Digital Assets [Member]
HYPE Digital Assets
HYPE digital assets
Represents information pertaining to HYPE LSTs.
Hype Liquid Staked Tokens [Member]
HYPE LSTs
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Liquidity Plan [Line Items]
Management's Liquidity Plans
Amount of working capital, calculated as the difference between a company's current assets and current liabilities.
Working Capital Deficit
Working capital
Period of unstaking que for crypto assets.
Crypto Asset, Unstaking Que Period
Number of days in unstaking que
Schedule of information pertaining to accounting policies in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Accounting Policies Disclosure [Table]
Indefinite-Lived Intangible Assets [Axis]
Indefinite-Lived Intangible Assets, Major Class Name [Domain]
Licensing Agreements [Member]
License
Range [Axis]
Range [Domain]
Maximum [Member]
Maximum
Minimum [Member]
Minimum
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
This member stands for Arctic Vision License Agreement in.
Arctic Vision License Agreement [Member]
Arctic Vision License Agreement
This member stands for Bausch License Agreement.
Bausch License Agreement [Member]
Bausch License Agreement
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Accounting Policies Disclosure [Line Items]
Summary of Significant Accounting Policies
The amount allocated to treasury bill.
US Treasury Bill Securities
US Treasury bill securities
Cash, Uninsured Amount
Cash, uninsured amount
Asset Impairment Charges
Asset impairments
Impairment, Long-Lived Asset, Held-for-Use
Impairment of long-lived assets
Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]
Impairment of Intangible Assets, Finite-Lived
Impairment of intangible assets
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of property, plant and equipment.
Impairment Of Property, Plant And Equipment
Impairment of property, plant and equipment
The charge against earnings resulting from the write down of long lived assets relating to equipment deposits due to the difference between the carrying value and lower fair value.
Impairment Of Equipment Deposits
Impairment of equipment deposits
Operating Lease, Impairment Loss
Operating lease right-of-use assets
Maximum amount of additional payments receivable by the company pursuant to a license agreement.
License Agreements Maximum Additional Payments Receivable
Maximum additional payments receivable
Amount of aggregate potential milestone revenues related to filing of Marketing Authorization Application.
License Agreement Filing Of Marketing Authorization Applications
Aggregate milestone revenue related to filing of marketing authorization applications
Amount of receipt of regulatory approvals.
License Agreement Regulatory Approvals
Receipt of regulatory approvals
Amount of royalty revenue payment earned during period.
Royalty Revenue Payments
Royalty payments earned
Represents the range1 percentage of royalty to be transferred to related party as per agreement.
Percentage Of Royalty To Be Transferred, Range1
Percentage of payment of royalties
Represents the number of days of written notice period for the termination of agreement.
Written Notice Period For Termination Of Agreement
Written notice period
Amount of cash outflow as upfront payment during the period relating to reacquisition of license rights.
License Agreement, Upfront Payment Paid
Upfront payment paid
Amount of upfront payments received by the entity, pursuant to a license agreement.
License Agreements Upfront Payments Received
Upfront payment received
Value of stock issued on transfer date in connection with the reacquisition of license rights.
Value Of Stock Issued For Reacquisition Of License Rights On Transfer Date
License rights on transfer date
Loss Contingency, Estimate of Possible Loss
Current estimated loss
Receivable related to amount previously held to be received upon completion of milestone.
Loss Contingency, Receivable Upon completion of Milestone
Receivable upon completion of milestone
Purchased related to amount previously held to be received upon completion of milestone.
Loss Contingency, Purchased Upon completion of Milestone
Purchased upon completion of milestone
Measurement Frequency [Axis]
Measurement Frequency [Domain]
Fair Value, Recurring [Member]
Recurring
Measurement Basis [Axis]
Portion at Fair Value Measurement [Member]
Reported Value Measurement [Member]
Carrying Values
Estimate of Fair Value Measurement [Member]
Fair Value
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV [Domain]
Fair Value, Inputs, Level 1 [Member]
Level 1
Fair Value, Inputs, Level 2 [Member]
Level 2
Represents information pertaining to KNTQ digital assets.
KNTQ Digital Assets [Member]
KNTQ digital assets
KNTQ Digital Assets
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net Loss Per Share of Common Stock
Dilutive Securities, Effect on Basic Earnings Per Share
Dilutive securities outstanding
Numerator:
Denominator (weighted average quantities):
Weighted Average Number of Shares Issued, Basic
Common shares issued
Weighted Average Number of Shares, Restricted Stock
Add: Undelivered vested restricted shares
Antidilutive Securities [Axis]
Antidilutive Securities, Name [Domain]
Options
Warrant [Member]
Warrants
Restricted Stock Units (RSUs) [Member]
Restricted stock units
Unvested RSU
Convertible Debt [Member]
Convertible debt
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Potentially dilutive shares
Amount of Payroll Taxes Receivable.
Payroll Taxes Receivable
Payroll tax receivable
Prepaid Insurance
Prepaid insurance expenses
Represents the information pertaining to Prepaid general and administrative expenses.
Prepaid General and Administrative Expenses
Prepaid general and administrative expenses
Amount of prepaid patent expense.
Prepaid Patent Expense
Prepaid patent expenses
Other Assets, Current
Other
Amount write down for prepaid regulatory expenses due to uncertainty in company products and strategic alternatives.
Prepaid Regulatory Expenses, Write Off
Prepaid regulatory expenses
Schedule of Indefinite-Lived Intangible Assets [Table]
Counterparty Name [Axis]
Counterparty Name [Domain]
Represents the information pertaining to Formosa Pharmaceuticals Inc.
Formosa Pharmaceuticals Inc [Member]
Formosa Pharmaceuticals Inc
Indefinite-Lived Intangible Assets [Line Items]
Digital Assets
Other Intangible Assets
Percentage of product approved by FDA.
Percentage of Product Approved by FDA
Percentage of product approved by FDA
Amount of upfront payment made.
Upfront Payment
Upfront payment
Upfront payment paid in cash
Upfront Payment Paid in Cash
Upfront payment paid in cash
Legal expenses capitalized.
Legal Expenses Capitalized
Legal expenses capitalized
Maximum amount payable upon achievement of certain development milestones.
Maximum Amount Payable Upon Achievement Of Certain Development Milestones
Maximum amount payable upon achievement of certain development milestones
Maximum amount payable upon achievement of certain sales milestones.
Maximum Amount Payable Upon Achievement of Certain Sales Milestones
Maximum amount payable upon achievement of certain sales milestones
Amount of initial development milestone payment which trigger FDA approval.
Initial Development Milestone Payment, Trigger For Fda Approval
Initial development milestone payment which trigger FDA approval
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]
Amount of license obligations payable for intangible assets.
Intangible Assets, license Obligations, Payable
Total obligations
Crypto Asset, Holding [Table]
Represents information pertaining to digital assets receivable.
Digital Assets Receivable [Member]
Digital Assets Receivable
Crypto Asset, Holding [Line Items]
Digital Assets
Number of crypto asset units staked by the entity.
Crypto Asset, Number of Units, Staked
Number of units staked
Number of crypto asset units on which staking reward has been received.
Crypto Asset, Number of Units, Reward Received
Number of units of reward received
Amount of increase in crypto asset as a result of receipt and accrual from native staking activities.
Crypto Asset, Receipt And Accrual From Native Staking Activities
Receipt and accrual of HYPE from native staking activities
Represents the member information pertaining to Hype Asset Use Service Agreement.
Hype Asset Use Service Agreement [Member]
Hype Asset Use Service Agreement
Interest Income, Operating
Interest income
Amount of realized credit losses on digital assets receivable during the reporting period.
Crypto Assets Receivable, Realized Credit Losses
Realized credit losses
Crypto Asset, Activity [Table]
Represents information pertaining to Digital intangible assets.
Digital Intangible Assets [Member]
Digital Intangible Assets
Crypto Asset, Activity [Line Items]
Digital Assets
Crypto Asset [Roll Forward]
Reconciliation of Company's assets and (liabilities) related to its digital assets
Fair value of crypto asset. Excludes crypto asset held for platform user.
Crypto Assets, Fair Value
Ending balance
Beginning balance
Crypto Asset, Purchase
Purchase of crypto asset
Purchases
Amount of decrease in crypto asset from disposition. Excludes crypto asset held for platform user.
Crypto Asset, Dispositions
Deposits of HYPE into liquid staking activities
Amount of increase in crpto asset resulting from purchases through liquid staking activities during the reporting period.
Crypto Asset, Purchased From Liquid Staking
Receipts of HYPE from liquid staking activities
Amount of commission paid in connection with crypto asset transactions during the reporting period.
Crypto Asset, Commission Expense
Commission paid to co-validators
Amount of crypto assets acquired during the reporting period for which delivery is contractually due.
Crypto Asset Receivable, Purchases
Purchase of digital asset receivable for HYPE
Amount of unrealized gain (loss) from remeasurement of crypto assets, classified as operating. Excludes crypto asset held for platform user.
Crypto Assets, Unrealized Gain (Loss), Operating
Unrealized loss
Amount of realized gain from remeasurement of crypto asset included in net income that results in no cash inflow (outflow).
Non-Cash Realized Gain On Crypto Asset
Realized gain
Represents the amount of impairment on crypto assets
Crypto Asset, Impairment
Impairment
Crypto Asset, Number of Units
Digital Assets, Units
Crypto Asset, Cost
Digital Assets, Cost Basis
Represents information pertaining to HiHYPE liquid staking token.
Hihype Liquid Staking Token [Member]
HiHYPE
Represents information pertaining to kHYPE liquid staking token.
Khype Liquid Staking Token [Member]
kHYPE
Represents information pertaining to kmHYPE liquid staking token.
Kmhype Liquid Staking Token [Member]
kmHYPE
Represents information pertaining to other digital assets.
Other Digital Assets [Member]
Other digital assets
Number of indefinite-lived intangible asset units held.
Indefinite Lived Intangible Assets, Number Of Units
Digital intangible assets, Units
Amount before impairment of assets, excluding financial assets and goodwill, lacking physical substance with a indefinite life.
Indefinite Lived Intangible Assets (Excluding Goodwill), Gross
Digital intangible assets, Cost
Crypto Asset, Realized Gain, Operating
Operating income
Dividends Payable, Current
Accrued dividend
Amount of accrued rework of clinical supply returns current.
Accrued Rework of Clinical Supply Returns, Current
Accrued rework of clinical supply returns
Carrying value as of the balance sheet date of obligations incurred and payable for franchise taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Accrued Franchise Tax
Accrued franchise tax
Employee-related Liabilities, Current
Accrued compensation expense
Amount of accrued research and development expenses paid by the entity.
Accrued Research And Development Expenses Current
Accrued research and development expenses
Accrued Professional Fees, Current
Accrued professional services
Taxes Payable, Current
Accrued foreign tax
Other Accrued Liabilities, Current
Other accrued expenses
Accrued Liabilities and Other Liabilities
Total accrued expenses and other current liabilities
Schedule reflecting a long term notes to be paid to the borrowers.
Schedule of Notes Payable [Table]
Debt Instrument [Axis]
Debt Instrument, Name [Domain]
Represents the information pertaining to Avenue - Note payable.
Avenue - Note Payable [Member]
Avenue - Note payable
Represents the information pertaining to Avenue - Convertible note payable
Avenue - Convertible Note Payable [Member]
Avenue - Convertible note payable
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Notes Payable [Line Items]
Notes Payable
Notes Payable, Current [Abstract]
Current portion
Notes Payable, Current
Notes Payable
Debt Instrument, Unamortized Discount, Current
Debt Discount
Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable, net of debt discount due within one year or the operating cycle if longer.
Notes Payable Current, Net Of Debt Discount Current, Current Portion
Net
Schedule of Short-term Debt [Table]
Represents the information pertaining to Loan and Security Agreement with Avenue, the Lender.
Loan and Security Agreement with Avenue Venture Opportunities Fund, L.P., and Avenue Venture Opportunities Fund, L.P. II [Member]
Avenue Ventures Loan
Lender Name [Axis]
Line of Credit Facility, Lender [Domain]
Represents the information pertaining to Avenue Venture Opportunities Fund, L.P., and Avenue Venture Opportunities Fund, L.P. II. and together with Avenue, the Lender.
Avenue Venture Opportunities Fund, L.P., and Avenue Venture Opportunities Fund, L.P. II [Member]
Avenue, the Lender
Represents the information pertaining to Avenue Venture Opportunities Fund, L.P. II.
Avenue Venture Opportunities Fund, L.P. II [Member]
Avenue 2
Scenario [Axis]
Scenario, Unspecified [Domain]
Represents the information pertaining to initial tranche of Avenue Loan.
Initial Tranche of Avenue Loan [Member]
Initial tranche of Avenue Loan
Represents the information pertaining to additional tranche of Avenue Loan.
Additional Tranche Of Avenue Loan [Member]
Additional tranche Of avenue loan
Represents information pertaining to a scenario specifying where the company raises fund till the specified threshold limit in the offering.
Until Company Raises Threshold Proceeds In Offering [Member]
Until Company Raises Threshold Proceeds In Offering
Represents information pertaining to a scenario specifying where the company raises fund after the specified threshold limit in the offering.
After Company Raises Threshold Proceeds In Offering [Member]
After Company Raises Threshold Proceeds In Offering
Measurement Input Type [Axis]
Measurement Input Type [Domain]
Measurement Input, Discount Rate [Member]
Discount rate
Measurement Input, Share Price [Member]
Share price
Measurement Input, Price Volatility [Member]
Expected volatility
Volatility
Measurement Input, Expected Dividend Rate [Member]
Dividend rate
Measurement Input, Risk Free Interest Rate [Member]
Risk free interest rate
Class of Warrant or Right [Axis]
Class of Warrant or Right [Domain]
Represents the information pertaining to lender warrants.
Lender Warrants [Member]
Lender Warrants
Short-term Debt [Line Items]
Notes Payable
Debt Instrument, Face Amount
Aggregate principal amount
Debt Instrument, Convertible, Conversion Price
Conversion price
Debt Instrument, Interest Rate, Stated Percentage
Interest rate (as a percent)
Debt Instrument, Basis Spread on Variable Rate
Basis spread on variable rate
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]
Debt Instrument, Unused Borrowing Capacity, Amount
Additional borrowing amount
Long-Term Debt, Gross
Debt gross amount
Debt Issuance Costs, Net
Payment of origination and legal fees
Debt instrument extension of interest period.
Debt Instrument Extension Of Interest Period
Extension of interest period
Percent of the required periodic payments applied to interest.
Debt Instrument, Incremental Final Payment, Interest Rate
Incremental final payment (as percent)
Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid
Final Payment premium
Represents the period of monthly interest-only payments in the debt instrument.
Debt Instrument, Monthly Interest Only Payment, Term
Monthly interest-only payments period (in months)
The amount of loan final payment.
Debt Instrument Final Payment
Final payment of loan
Debt Instrument, Periodic Payment, Principal
Initial principal payment related to loan and security agreement
Threshold number of specified trading days to calculate volume weighted average price per share.
Volume Weighted Average Price, Threshold Trading Days
Number of trading days
Shares Issued, Price Per Share
Shares Issued price per share
Threshold aggregate proceeds, net of fees and commission from issuance of stock under the offering.
Threshold Aggregate Net Proceeds From Issuance Of Stock
Threshold aggregate net proceeds from issuance of stock
Percentage of proceeds agreed to be remitted to lender under the agreement.
Percentage Of Proceeds To Be Remitted To Lender
Percentage of proceeds to be remitted to lender
The cash outflow associated with principal amount of debt on debt restructuring.
Debt Restructuring, Principal Amount Repaid
Debt restructuring principal amount repaid
The cash outflow associated with interest amount of debt on debt restructuring.
Debt Restructuring, Interest Amount Repaid
Debt restructuring interest amount repaid
Repayments of notes payable as percentage of net proceeds received from sale of stock in the offering.
Repayments Of Notes Payable As Percentage Of Net Proceeds From Offering
Repayments of notes payable as percentage of net proceeds from offering
The negotiated adjustment to the outstanding balance of the debt on debt restructuring.
Debt Restructuring, Negotiated Adjustment
Debt restructuring negotiated adjustment
Debt Conversion, Original Debt, Amount
Aggregate amount
The amount of the discount on debt being converted in a noncash (or part noncash) transaction.
Debt Conversion, Discount on Conversion
Debt conversion discount on conversion
Debt Conversion, Converted Instrument, Shares Issued
Debt conversion converted instrument, shares issued
Debt Instrument, Measurement Input
Measurement input
The threshold percentage of beneficial interest that can be owned after conversion of debt instrument.
Debt Conversion, Threshold Percentage on Beneficial Ownership
Debt conversion, threshold percentage on beneficial ownership
The notice period for effective beneficial ownership on conversion of debt instrument.
Debt Conversion, Notice Period for Effective Beneficial Ownership
Debt conversion, notice period for effective beneficial ownership
The amount of the original debt being eliminated from debt conversion.
Debt Conversion, Elimination of Conversion Option, Original Debt Amount
Debt conversion, elimination of debt amount
The amount of final payment cancelled under the debt instrument.
Debt Instrument, Cancellation of Final Payment
Debt instrument, cancellation of final payment
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Number of warrants issued
Warrants and Rights Outstanding, Term
Term of warrant
Class of Warrant or Right, Exercise Price of Warrants or Rights
Warrants Outstanding, Exercise price
Exercise price
Warrants and Rights Outstanding
Warrants and rights outstanding
Warrants and Rights Outstanding, Valuation Technique [Extensible Enumeration]
Warrants and Rights Outstanding, Measurement Input
Warrants and rights outstanding measurement input
Gains (Losses) on Restructuring of Debt
Gain on restructuring of debt
Interest Expense, Debt
Interest expense
Amortization of Debt Discount (Premium)
Amortization of debt discount
Short-term Debt, Type [Axis]
Short-term Debt, Type [Domain]
Represents information pertaining to Directors And Officers Insurance Policy Loan.
Directors and Officers Insurance Policy Loan [Member]
Directors and officers' liability insurance policy
Debt Instrument, Maturity Date
Maturity date
Number of monthly payments.
Number Of Monthly Payments
Number of monthly payments
Debt Instrument, Periodic Payment
Debt Instrument, Periodic Payment
Current Federal, State and Local, Tax Expense (Benefit) [Abstract]
Current tax (provision) benefit:
Current State and Local Tax Expense (Benefit)
State and local
Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]
Deferred tax (provision) benefit:
Deferred Federal Income Tax Expense (Benefit)
Federal
Deferred State and Local Income Tax Expense (Benefit)
State and local
Amount of deferred income tax expense (benefit) before adjustments for change in valuation allowance.
Deferred Income Tax Expense (Benefit) Before Adjustments for Change in Valuation Allowance
Total
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Changes in valuation allowance
Income Tax Expense (Benefit)
Provision for income taxes
Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]
Tax reconciliation, amount
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
US Federal statutory tax rate
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount
State and local taxes, net of federal income tax effect
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to unusable tax credits.
Effective Income Tax Rate Reconciliation, Unusable Tax Credits, Amount
Tax credits
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
Changes in valuation allowance
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes or nondeductible expenses.
Income Tax Reconciliation, Tax Exempt Income Or Nondeductible Expense, Amount
Nontaxable or nondeductible items
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Other reconciling items related to net operating losses
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments related to prior period deferred.
Effective Income Tax Rate Reconciliation, Other Adjustments Related To Prior Period Deferred, Amount
Other reconciling items related to prior period deferreds
Tax Jurisdiction of Domicile [Extensible Enumeration]
Effective Income Tax Rate Reconciliation, Percent [Abstract]
Tax reconciliation, percent
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
US Federal statutory tax rate
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent
State and local taxes, net of federal income tax effect
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent
Research & development tax credits
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.
Effective Income Tax Rate Reconciliation Unusable Tax Credits Percent
Tax credits
Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent
Prior period adjustments and other
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent
Rate and apportionment changes
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Changes in valuation allowance
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes or nondeductible expenses.
Effective Income Tax Reconciliation, Tax Exempt Income Or Nondeductible Expense, Percent
Nontaxable or nondeductible items
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Other reconciling items related to net operating losses
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments related to prior period deferred.
Effective Income Tax Rate Reconciliation, Other Adjustments Related To Prior Period Deferred, Percent
Other reconciling items related to prior period deferreds
Effective Income Tax Rate Reconciliation, Percent
Effective income tax rate
Income Tax Paid, by Individual Jurisdiction [Table]
Income Tax Authority [Axis]
Income Tax Authority [Domain]
State and Local Jurisdiction [Member]
State
NEW YORK
New York
Represents information pertaining to New York City.
New York City [Member]
New York City
State and Local Tax Jurisdiction, Other [Member]
All other states
Income Tax Paid, by Individual Jurisdiction [Line Items]
Income Taxes
Income Tax Paid, State and Local, after Refund Received
State and local
Deferred Tax Assets, Net [Abstract]
Deferred tax assets:
Deferred Tax Assets, Operating Loss Carryforwards
Net operating loss carryforwards
Deferred Tax Assets, in Process Research and Development
Research and development tax credits
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences fromcapitalized research and development costs expensed in connection with a business combination.
Deferred Tax Assets Capitalized Research And Development Costs
Capitalized research and development costs
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
Stock-based compensation
Deferred Tax Assets, Goodwill and Intangible Assets
Intangible assets
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible lease liability.
Deferred Tax Assets Lease Liabilities
Lease liability
It represents the amount of deferred tax assets, other impaired assets.
Deferred Tax Assets, Other Impaired Assets
Other impaired assets
Deferred Tax Assets, Property, Plant and Equipment
Property and equipment
Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from unrealized gain (loss) on crypto assets.
Deferred Tax Assets, Unrealized Gain (Loss) On Crypto Assets
Unrealized gain/loss on digital assets
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
Current expected credit loss
Deferred Tax Assets, Gross
Total gross deferred tax assets
Deferred Tax Assets, Valuation Allowance
Valuation allowance
Valuation allowance
Deferred Tax Assets, Net of Valuation Allowance
Deferred tax assets, net of valuation allowance
Components of Deferred Tax Liabilities [Abstract]
Deferred tax liabilities
Deferred Tax Liabilities, Leasing Arrangements
Right of use asset
Deferred Tax Liabilities, Net
Deferred tax liabilities, net
Amount of increase (decrease) in the valuation allowances for a specified deferred tax asset.
Valuation Allowances, Deferred Tax Asset, Increase (Decrease), Amount
Changes in valuation allowance
Operating Loss Carryforwards [Table]
Member represents State Jurisdiction.
State [Member]
State
Operating Loss Carryforwards [Line Items]
Income Taxes
Operating Loss Carryforwards
Operating loss carryforwards
Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration
Operating loss carryforwards, subject to expiration
The expiry term of carryforward operating losses.
Operating Loss Carry forwards Expiration Term
Operating loss carry forwards expiration term
Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration
Operating loss carryforwards, not subject to expiration
This represents Annual utilization limit.
Net Operating Loss Annual Utilization Limit as per Internal Revenue Code
Net operating loss annual utilization limit as per internal revenue code
Amount of net operating loss carryforwards that is not realizable due to limitations resulting from an ownership change.
Net Operating Loss Carryforwards, Limited By Ownership Change
Operating loss carryforward not realizable due to ownership change
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
Tax related interest or penalties
Loss Contingencies [Table]
Represents information pertaining to Credo Cayman.
Credo Cayman [Member]
Credo Cayman
Represents information pertaining to Hyperion and Felix.
Hyperion and Felix [Member]
Hyperion and Felix
Represents information pertaining to Native Markets, Inc.
Native Markets Inc [Member]
Native Markets Inc
Loss Contingencies [Line Items]
Commitments and Contingencies
Number of crypto asset units linked to trading wallet.
Crypto Asset, Number Of Units Linked To Trading Wallet
Number of units linked to trading wallet
It represents the percentage Market revenues based on trading volume tiers, plus of staking rewards.
Market Revenues Percentage
Market revenues percentage
Initial period for which the Hype asset use service agreement is being entered into for joint operations, validations and attestation of the blocks and consensus protocol of the digital assets, expressed in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Crypto Asset, Hype Asset Use Service Agreement, Initial Term
HAUS Agreement initial term
Automatic renewable for which the Hype asset use service agreement is being entered into for joint operations, validations and attestation of the blocks and consensus protocol of the digital assets, expressed in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Crypto Asset, Hype Asset Use Service Agreement, Automatic Renewable
HAUS Agreement automatic renewable periods
Terminated notice for which the Hype asset use service agreement is being entered into for joint operations, validations and attestation of the blocks and consensus protocol of the digital assets, expressed in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Crypto Asset, Hype Asset Use Service Agreement, Terminated Notice
HAUS Agreement terminated notice period
Threshold written notice period for termination Hype asset use service agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Crypto Asset, Hype Asset Use Service Agreement, Threshold Prior Written Notice Period For Termination
Threshold prior written notice period for termination
Number of crypto asset units allocated to a multi-signature wallet.
Crypto Asset, Number Of Units Allocated To Multi Signature Wallet
Number of units allocated to a multi-signature wallet
Initial period for which the temporary use service agreement is being entered, expressed in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Crypto Asset, Temporary Use Agreement, Initial Term
Temporary use agreement, initial term
Automatic renewable term crypto asset in temporary use agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Crypto Asset, Temporary Use Agreement, Automatic Renewable
Temporary use agreement, automatic renewable
Threshold notice period for non-renewal in temporary use agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Crypto Asset, Temporary Use Agreement, Threshold Notice Period For Non Renewal
Temporary use agreement, threshold notice of nonrenewal
Represents information pertaining to Kinetiq Research Pte ("Kinetiq") and Pier Two Pty Ltd ("Pier Two").
Kinetiq Research Pte And Pier Two Pty Ltd [Member]
Kinetiq and Pier Two
Number of units of crypto asset initiated for stake by the entity under the joint validator agreement.
Crypto Asset, Number Of Units Initiated For Stake
Number of units initiated for stake
Initial period for which the joint validator agreement is being entered into for joint operations, validations and attestation of the blocks and consensus protocol of the digital assets, expressed in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Crypto Asset, Joint Validator Agreement, Initial Term
Joint validator agreement
Threshold period of prior notice to serve by the party to the joint validator agreement to terminate the contract expressed in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Crypto Asset, Joint Validator Agreement, Threshold Prior Notice Period
Notice period of agreement
Security Deposit
Security deposit in the amount
The amount of operating leases rent expense.
Operating Leases Rental Expense
Rent expense
Operating Lease, Payments
Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows used in operating activities
Operating Lease, Weighted Average Remaining Lease Term
Weighted Average Remaining Lease Term (Years): Operating leases
Operating Lease, Weighted Average Discount Rate, Percent
Weighted Average Discount Rate: Operating leases
Lessee, Operating Lease, Liability, to be Paid [Abstract]
Minimum Lease Payments
Lessee, Operating Lease, Liability, to be Paid, Year One
2026
Lessee, Operating Lease, Liability, to be Paid, Year Two
2027
Lessee, Operating Lease, Liability, to be Paid
Total future minimum lease payments
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Less: Imputed interest
Operating Lease, Liability
Present value of lease liabilities
This table may be used to disclose all the information related to related party transactions.
Related Party Transactions [Table]
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. References
Related Party Transactions [Line Items]
Related Party Transactions
Repayments of Related Party Debt
Repayments of Notes Payable
Repayment of notes payable, interest payment.
Repayment Of Notes Payable, Interest Payment
Interest payment
Represents information pertaining to prefunded warrants in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Pre-funded Warrants [Member]
Pre-funded warrants
This member stands for august 2022 offering.
Equity Offering August 2023 [Member]
Equity offering august 2023
Represents information pertaining to existing warrants.
Existing Warrants [Member]
Existing Warrants
Represents information pertaining to March 2022 Securities Purchase Agreement.
March 2022 Securities Purchase Agreement [Member]
March 2022 Securities Purchase Agreement
Represents information pertaining to September 2024 offering.
September 2024 Offering [Member]
September 2024 Offering
Represents information pertaining to November 2024 offering.
November 2024 Offering [Member]
November 2024 Offering
Represents information pertaining to December 2024 offering.
December 2024 Offering [Member]
December 2024 Offering
Represents information pertaining to January 2025 Inducement Offering.
January 2025 Inducement Offering [Member]
January 2025 Offering
The cash inflow from the additional capital contribution net of issuance costs to the entity.
Proceeds from Issuance of Common Stock Net of Issuance Costs
Net proceeds
Number of warrants issued during the period.
Class Of Warrants Or Rights, Number Of Warrants Issued
Number of warrants issued
Title of Individual [Axis]
Relationship to Entity [Domain]
Person with designation of Executive Chairman.
Executive Chairman [Member]
Executive Chairman
Period during which the medical expertise and consultation service would be provided, expressed in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Medical Expertise And Consultation Service Period
Medical expertise And consultation service period
Monthly retainer that will be paid to the officers of the company.
Monthly Retainer
The number of votes per share of common stock.
Number Of Votes Per Common Share
Number of votes
This table may be used to disclose all the information related to Stockholders Equity.
Stockholders Equity [Table]
Stockholders' Equity
Represents information pertaining to Merenti Management GmbH.
Merenti Management Gmbh [Member]
Merenti Management GmbH
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. References
Stockholders' Equity [Line Items]
Stockholders' Equity (Deficit)
Represents information pertaining to amended and restated sales agreement.
Amended And Restated Sales Agreement [Member]
Amended And Restated Sales Agreement
This member stands for December 2021 Sales Agreement.
December 2021 Sales Agreement [Member]
Represents the information pertaining to at-the-market offering program.
At Market Offering Program
Sale of Stock, Consideration Received on Transaction
Net proceeds from At-the-Market Offering Program
Proceeds from Issuance of Common Stock
Proceeds from issuance of common stock
Aggregate value of stock offered to for sale under the agreement.
Aggregate Offering Price
Aggregate offering price
The rate gross sale on common stock.
Percentage Of Gross Sales On Common Stock
Percentage on gross sale
Percentage of fee as commission for placement agent in connection with the offering.
Placement Agent Commission Fee Percentage
Placement agent, commission fee, percentage
Represents information pertaining to prior warrants.
Prior Warrants [Member]
Prior Warrants
Represents information relating to 2024 registered direct offering.
Registered Direct Offering 2024 [Member]
Registered Direct Offering
This member stands for July offering.
July offering [Member]
July offering
Common Class A [Member]
Common Class A
Common Class B [Member]
Common Class B
Aggregate number of shares of common stock offering
Stock Issued During Period, Shares, Offerings
Number of shares of common stock offering
Share Price
Number of additional securities into which the Additional class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.
Class Of Warrant Or Right Number Of Additional Securities Called By Additional Warrants Or Rights
Additional warrants
Exercise price per share or per unit of warrants or rights outstanding.
Class of Warrant or Right, Exercise Price of Warrants or Rights 2
Exercise price
Weighted average exercise price of warrants or rights new repriced.
Class of Warrant or Right, New Repriced, Weighted Average Exercise Price
Repriced - New
Proceeds from Issuance or Sale of Equity
Aggregate gross proceeds
The amount of expense provided in the period for placement agent fees in connection with offering.
Placement Agent Fees
Placement agent fees
Legal Fees
Legal fees
Price per share or per unit of warrants or rights outstanding.
Class of Warrant or Right, Price of Warrants or Rights
Price of Warrants
Gross cash inflow from exercise of warrants.
Gross Proceeds From Warrant Exercises
Gross proceeds from warrant exercises
This member stands for investor warrants.
Investor Warrants [Member]
Investor warrants
Represents the information pertaining to placement agent warrants.
Placement Agent Warrants [Member]
Placement agent warrants
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right
No. of common stock per warrant
Preferred Stock, Convertible, Conversion Ratio
Preferred stock convertible ratio
Preferred Stock, Dividend Rate, Percentage
Cumulative dividend rate
Fair Value Measurement Inputs and Valuation Techniques [Table]
Measurement Input, Expected Term [Member]
Expected term (years)
Represents information pertaining to assumptions used for valuation before modification of warrants.
Warrants Assumptions Used for Valuation, Before Modification [Member]
Before Modification
Represents information pertaining to assumptions used for valuation after modification of warrants.
Warrants Assumptions Used for Valuation, After Modification [Member]
After Modification
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Represents the member information pertaining to scenario, reduction in exercise price of warrants if investor immediately exercised warrants.
Reduction in Exercise Price of Warrants If Investor Immediately Exercised Warrants [Member]
Reduction in Exercise Price of Warrants If Investor Immediately Exercised Warrants
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
Class Of Warrants Or Rights Outstanding [Rollforward]
Number of Warrants
Class of Warrant or Right, Outstanding
Outstanding at ending balance
Outstanding at beginning balance
Number of warrants or rights issued during the period.
Class Of Warrant Or Right Issued
Issued
Number of warrants or rights old repriced during the period.
Class of Warrant or Right, Old Repriced
Repriced - Old
Number of warrants or rights new repriced during the period.
Class of Warrant or Right, New Repriced
Repriced - New
Number of warrants or rights expired during the period.
Class Of Warrant Or Right Expired
Expired
Number of warrants or rights exercised during the period.
Class of Warrant or Right, Exercised
Exercised
Number of warrants or rights exercisable.
Class of Warrant or Right, Exercisable
Exercisable Number of warrants
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
Class Of Warrants Or Rights, Weighted Average Exercise Price [Rollforward]
Weighted Average Exercise Price
Weighted average exercise price of warrants or rights outstanding.
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price
Outstanding at ending balance
Outstanding at beginning balance
Weighted average exercise price of warrants or rights issued during the period.
Class Of Warrant Or Right Issued Weighted Average Exercise Price
Issued
Weighted average exercise price of warrants or rights old repriced.
Class of Warrant or Right, Old Repriced, Weighted Average Exercise Price
Repriced - Old
Weighted average exercise price of warrants or rights expired during the period.
Class Of Warrant Or Right Expired Weighted Average Exercise Price
Expired
Weighted average exercise price of warrants or rights exercised during the period.
Class of Warrant or Right, Exercised, , Weighted Average Exercise Price
Exercised
Weighted average exercise price of warrants or rights exercisable.
Class of Warrant or Right, Exercisable, Weighted Average Exercise Price
Exercisable
Weighted average remaining life of warrants or rights outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Class of Warrant or Right, Outstanding, Weighted Average Remaining Life
Weighted Average Remaining Life In Years, Outstanding
Weighted average remaining life of warrants or rights exercisable, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Class of Warrant or Right, Exercisable, Weighted Average Remaining Life
Weighted Average Remaining Life In Years, Exercisable
Warrants Exercisable, Average Remaining Life In Years
Aggregate intrinsic value of warrants or rights outstanding.
Class Of Warrant Or Right Outstanding Aggregate Intrinsic Value
Aggregate Intrinsic Value, Outstanding, at ending balance
Aggregate Intrinsic Value, Outstanding, at beginning balance
Aggregate intrinsic value of warrants or rights exercisable.
Class Of Warrant Or Right Exercisable Aggregate Intrinsic Value
Aggregate Intrinsic Value, Exercisable
The cash inflow associated with the net amount received from holders exercising their stock warrants.
Net Proceeds from Warrant Exercises
Net proceeds from warrant exercises
The cash outflow for cost incurred directly with the issuance of warrants.
Payments for Warrants Issuance Costs
Payments for warrants issuance costs
An excess of the fair value of the modified warrants over the fair value of the warrants immediately before the modification.
Warrants Modification, Incremental Costs
Warrants modification, Incremental costs
Class of Warrant or Right [Table]
This member stands for warrants with the first exercise price.
Warrants At Exercise Price One [Member]
Warrants at exercise price of $3.2500
This member stands for warrants with the second exercise price.
Warrants At Exercise Price Two [Member]
Warrants at exercise price of $4.0000
This member stands for warrants with the third exercise price.
Warrants At Exercise Price Three [Member]
Warrants at exercise price of $5.2720
This member stands for warrants with the fourth exercise price.
Warrants At Exercise Price Four [Member]
Warrants at exercise price of $8.6080
Represents information pertaining to warrants at exercise price nine.
Warrants At Exercise Price Nine [Member]
Warrants at exercise price of $197.5680
Represents information pertaining to warrants at exercise price ten.
Warrants At Exercise Price Ten [Member]
Warrants at exercise price of $217.9200
Represents information pertaining to warrants at exercise price seven.
Warrants At Exercise Price Seven [Member]
Warrants at exercise price of $380.8000
Class of Warrant or Right [Line Items]
Stockholders' Equity
Number of warrants or right outstanding.
Class Of Warrants Or Right Outstanding
Warrants Outstanding, Weighted outstanding Number of Warrants
Number of warrant or right exercisable.
Class of Warrants or Right, Exercisable
Warrants Exercisable, Exercisable Number of Warrants
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Income Statement Location [Axis]
Income Statement Location [Domain]
Research And Development Expense [Member]
Research and Development Expense
Research and development
Selling, General and Administrative Expenses [Member]
Selling, general and administrative
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stockholders' Equity (Deficit)
Share-Based Payment Arrangement, Expense
Stock-based compensation expense
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Number of RSUs
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
RSUs non-vested December 31, 2025
RSUs non-vested January 1, 2025
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Granted
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
Vested
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Forfeited
The number of equity-based payment instruments, excluding stock (or unit) options, that vested RSUs Undelivered numbers during the reporting period.
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested R S Us Undelivered, Number
Vested RSUs undelivered December 31, 2025
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Outstanding Weighted Average Exercise Price [Roll forward]
Weighted Average Grant Date Price
Weighted average price at which grantees can acquire the shares reserved for issuance under the restricted stock unit plan.
Share-based Compensation Arrangement by Share-based Payment Award, Other Than Options, Non Vested, Outstanding, Weighted Average Exercise Price
RSUs non-vested December 31, 2025
RSUs non-vested January 1, 2025
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of restricted stock units.
Share-based Compensation Arrangement by Share-based Payment Award, Other Than Options, Grants In Period, Weighted Average Exercise Price
Granted
Weighted average per share amount at which grantees vested the restricted stock units.
Share-based Compensation Arrangement by Share-based Payment Award, Other Than Options, Vested In Period, Weighted Average Exercise Price
Vested
Weighted average price at which grantees could have acquired the underlying shares with respect to restricted stock units that were terminated.
Share-based Compensation Arrangement by Share-based Payment Award, Other Than Options, Forfeited In Period, Weighted Average Exercise Price
Forfeited
Weighted average per share amount at which grantees vested the restricted stock units undelivered.
Share-based Compensation Arrangement by Share-based Payment Award, Other Than Options, Vested R S Us Undelivered, Weighted Average Exercise Price
Vested RSUs undelivered December 31, 2025
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stockholders' Equity (Deficit)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Risk free interest rate
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term
Term (years)
Expected term (years)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Volatility
Expected volatility
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Expected dividends
Dividends
Derivative Instrument [Axis]
Derivative Contract [Domain]
Stock Option [Member]
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Number of Options, Outstanding | Shares
Number of Options, Outstanding | Shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Number of Options, Granted | Shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Number of Options, Forfeited/Expired | Shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Number of Options, Exercisable | Shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Weighted Average Exercise Price, Outstanding | $ / Shares
Weighted Average Exercise Price, Outstanding | $ / Shares
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Weighted average estimated grant date fair value
Weighted Average Exercise Price, Granted | $ / Shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Weighted Average Exercise Price, Forfeited/Expired | $ / Shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Weighted Average Exercise Price, Exercisable | $ / Shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Weighted Average Remaining Life In Years, Outstanding
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Weighted Average Remaining Life In Years, Exercisable
Exercise Price Range [Axis]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]
This member represents for exercise price one.
Exercise Price One [Member]
Exercise Price $0.01 - $19.99
This member represents for exercise price two.
Exercise Price Two [Member]
Exercise Price $20.00 - $59.99
This member represents for exercise price three.
Exercise Price Three [Member]
Exercise Price $60.00 - $99.99
This member represents for exercise price four.
Exercise Price Four [Member]
Exercise Price $100.00+
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price
Options Outstanding, Outstanding Exercise Price
Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding
Options Outstanding, Outstanding Number of Options
Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term
Options Exercisable, Weighted Average Remaining Life In Years
Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable
Options Exercisable, Exercisable Number of Options
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Risk free interest rate minimum
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
Risk free interest rate maximum
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum
Expected volatility minimum
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
Expected volatility maximum
Plan Name [Axis]
Plan Name [Domain]
The member stands for omnibus stock incentive plan 2018.
Omnibus Stock Incentive Plan 2018 [Member]
Omnibus Stock Incentive Plan 2018
Common Stock, Capital Shares Reserved for Future Issuance
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period
Vesting period
Amount of cash fees paid subject to certain exceptions for a non-executive chair of the Board.
Share-based Compensation Arrangement by Share-based Payment Award, Cash Fee Paid
Cash fee paid
Represents the number of executive officers entered into employment agreements
Number of Executive Officers Entered into Employment Agreements
Number of executive officers entered into employment agreements
Represents the number of tranches in which the market-based grants vest.
Number of Tranches in Which Market-Based Grants Vest
Number of tranches in which the market-based grants vest
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
Unrecognized stock-based compensation expense
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options
Unrecognized stock-based compensation expense related to stock options
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition
Weighted average period of recognition
Defined Contribution Plan [Table]
Defined Contribution Plan Disclosure [Line Items]
Employee Benefit Plans
Defined Contribution Plan, Employer Matching Contribution, Percent of Match
Defined contribution plan, employer matching contribution, percent of match
Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage
Defined contribution plan, employers matching contribution, annual vesting percentage
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount
Defined contribution plan, maximum annual contributions per employee, amount
Defined Contribution Plan, Increase (Decrease), Cost
Defined contribution plan, reduction in expenses
Number of Operating Segments
Number of operating segments
Number of Reportable Segments
Number of reporting segments
Schedule of Segment Reporting Information, by Segment [Table]
Segments [Axis]
Segments [Domain]
Represents information pertaining to ophthalmic technology.
Ophthalmic Technology Segment [Member]
Ophthalmic Technology
Represents information pertaining to digital assets.
Digital Assets [Member]
Digital Assets
Consolidation Items [Axis]
Consolidation Items [Domain]
Operating Segments [Member]
Operating Segments
Represents information pertaining to corporate and reconciling items.
Corporate and Reconciling Items [Member]
Corporate / Other
Segment Reporting Information [Line Items]
Segment Reporting
Operating Expenses [Abstract]
Less:
Research and Development Expense [Abstract]
Research and Development:
Amount of expense for salaries and other employee benefits attributable to research and development.
Research and Development Expense, Salaries And Benefits
Salaries and benefits
Amount of expense for direct clinical and non-clinical expenses attributable to research and development.
Research and Development Expense, Direct Clinical And Non Clinical Expenses
Direct clinical and non-clinical expenses
Amount of expense for facilities attributable to research and development.
Research and Development Expense, Facilities Expenses
Facilities expenses
Amount of non-cash stock based compensation expenses attributable to research and development.
Research and Development Expense, Non Cash Stock Based Compensation Expense
Non-cash stock based compensation expenses
Amount of expense for supplies and materials attributable to research and development.
Research and Development Expense, Supplies And Materials
Supplies and materials
Other Research and Development Expense
Other Expenses
Amount of depreciation expense attributable to research and development.
Research and Development Expense, Depreciation Expense
Depreciation expense
The net result for the period of deducting operating expenses from operating revenues reconciling items.
Operating Income Loss Excluding Reconciling Items
Segment loss
Reconciliation of Assets from Segment to Consolidated [Table]
Segment Reporting, Asset Reconciling Item [Line Items]
Segment Reporting
Crypto Asset, Fair Value
Digital assets
Other Assets
All other assets
Subsequent Event [Table]
Subsequent Event Type [Axis]
Subsequent Event Type [Domain]
Subsequent Event
Subsequent Events
Represents information pertaining to Silhouette AG.
Silhouette A G [Member]
Silhouette AG
Subsequent Event [Line Items]
Subsequent Events
Number of crypto asset units purchased during the period.
Crypto Asset, Number of Units, Purchased
Number of units purchased
Preferred Stock Dividends, Shares
Preferred stock dividends shares
Non Rule 10b5-1 Arrangement Modified [Flag]
Non Rule 10b5-1 Arrangement Modified [Flag]
Non Rule 10b5-1 Arrangement Modified
Rule 10b5-1 Arrangement Modified [Flag]
Rule 10b5-1 Arrangement Modified [Flag]
Rule 10b5-1 Arrangement Modified